Nemus Bioscience, Inc. Announces Letter of Intent to

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Nemus Bioscience, Inc. Announces Letter of Intent to License Biosynthetic Technology to Manufacture Its Proprietary Cannabinoid Molecules From Teewinot Life Sciences Corp.

COSTA MESA, CA and TAMPA, FL--(Marketwired - Jun 10, 2016) - NEMUS Bioscience, Inc. ( OTCQB : NMUS ) announced it signed a letter of intent (LOI) with Teewinot Life Sciences Corp. that is expected to lead to signing of a license agreement in which NEMUS would license biosynthetically-derived cannabinoid molecules based on NEMUS' proprietary prodrug technology.

Teewinot is a global leader in the use of synthetic biology to create pharmaceutical grade cannabinoids. This week the company was granted the first U.S. Patent covering a commercial process for biosynthetic production of the cannabinoids THCA, CBDA and CBCA. The LOI terms contemplate the grant to Nemus of a license to sell products in all therapeutic indications globally using the Teewinot proprietary biosynthetic processes on NEMUS' proprietary molecules. Biosynthetic production offers the potential to improve purity and speed of production of cannabinoid molecules over traditional methods of deriving the molecules from plants or chemical synthesis.

"Teewinot will offer NEMUS a strategic and competitive advantage in the cannabinoid therapeutic marketplace by enabling our proprietary THC prodrug and unique CBD derivative molecules to be manufactured in a time-efficient manner, reducing synthesis time from months to days," said Brian Murphy, MD, MBA, the NEMUS CEO and CMO. "Additionally, biosynthesis provides cost of manufacturing advantages over traditional chemical synthesis methods, often reducing costs anywhere from 60-75 percent. We are impressed with the versatility of the biosynthesis system in the ability to produce an array of cannabinoids, which fits plans for our library of cannabinoid pipeline molecules developed with our research and commercialization partner, the University of Mississippi."

Jeffrey Korentur, CEO of Teewinot, said, "Our company is well-positioned to play an instrumental role in the burgeoning field of cannabinoid-based therapeutics, in the United States, and on a global scale. We look forward to collaborating with NEMUS and their partner, the University of Mississippi, which brings a 48-year history of cannabinoid-based research. Our collective expertise can optimally advance new therapies utilizing cannabinoid molecules."

"Teewinot, which is offering unique, innovative, and disruptive technology in the cannabinoid manufacturing space perfectly complements the disruptive drug design technology of the NEMUS prodrug platforms. Together, we may dramatically impact the therapeutic potential offered by cannabinoids across a spectrum of debilitating diseases," said Dr. Richard Peet, executive vice president of Teewinot.

Teewinot is scaling up its proprietary processes in collaboration with Albany Molecular Research, Inc., a leading U.S. contract research organization (CRO) and the current API manufacturer for NEMUS.

FORWARD LOOKING STATEMENTS

Statements in this press release that are not descriptions of historical facts are forward-looking statements that are based on management's current expectations and assumptions and are subject to risks and uncertainties, including statements about our expectation to enter into a license agreement and the terms of such license agreement. If such risks or uncertainties materialize or such assumptions prove incorrect, our business, operating results, financial condition and stock price could be materially negatively affected. In some cases, forward-looking statements can be identified by terminology including "goal," "focus," "aims," "believes," "can," "challenge," "predictable" "will," or the negative of these terms or other comparable terminology. We operate in a rapidly changing environment and new risks emerge from time to time. As a result, it is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements the Company may make. Risks and uncertainties that may cause actual results to differ materially include, among others, uncertainty regarding the results of future testing and development efforts and other risks that are described in the Risk Factors section of NEMUS' most recent annual or quarterly report filed with the Securities and Exchange Commission. Except as expressly required by law, NEMUS disclaims any intent or obligation to update these forward-looking statements.

ABOUT NEMUS BIOSCIENCE, INC.

The Company is a biopharmaceutical company, headquartered in Costa Mesa, California, focused on the discovery, development, and commercialization of cannabinoid-based therapeutics for significant unmet medical needs in global markets. Utilizing certain proprietary technology licensed from the University of Mississippi, NEMUS is working to develop novel ways to deliver cannabinoid-based drugs for specific indications, with the aim of optimizing the clinical effects of such drugs, while limiting the potential adverse events. NEMUS' strategy will explore the use of natural and synthetic compounds, alone or in combination. The Company is led by a highly qualified team of executives with decades of biopharmaceutical experience and significant background in early-stage drug development.

For more information, visit http://www.nemusbioscience.com .

About Teewinot Life Sciences Corporation

Teewinot Life Sciences Corporation is an international biopharmaceutical company focused on the use of synthetic biology and advanced formulation for the production and implementation of cannabinoid based therapies. With headquarters in Tampa, Florida, Teewinot manufactures and licenses technology to make cost effective, pharmaceutically pure authentic cannabinoids as an industry leader in support of advancing medical research and product development. Teewinot's global technology and intellectual property represent a breakthrough in the creation and delivery of cannabinoid based medicines. For more information, please visit www.tlscorp.com or follow us on Twitter (@teewinot_corp).

CONTACTS: NEMUS Investor Relations PCG Advisory Group Adam Holdsworth Email: adamh@pcgadvisory.com Phone: 646-862-4607 http://pcgadvisory.com/ NEMUS Media Relations Sean Leous Email: sleous@pcgadvisory.com Phone: 646-863-8998 Teewinot Media Relations Heather Pavliga Email: heather@horizonmarketing.com Phone: 813-781-5999

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Carolina Pines Tackles Rural Healthcare Myths on TV

Updated Category News Views 47

Rural Healthcare Battles the Big City Myth Picture this: you're in a tiny town where everyone knows your dog's name, but some think you've got to head to the city for top-notch medical care. That's where Carolina Pines Regional Medical Center steps in. They’ve snagged a spot on 'All Access with Andy Garcia', shining a light on how investments in tech and talent keep...

Continue Reading
Tips for a Dementia-Friendly Thanksgiving Gathering

Updated Category News Views 21

Thanksgiving's supposed to bring families round the table, right? But toss a few knuckleheads together, add a pinch of dementia, and suddenly it's like throwing dice at a craps table. The American Speech-Language-Hearing Association (ASHA) reckons they've got tricks up their sleeve to keep the holiday from unraveling. The Thanksgiving Reality Check The hustle, bustle, and...

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 385

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Mining Equipment Market to Surge, Hitting $42.81B by 2033

Updated Category News Views 20

Forecasts on Market Growth: A Robust Climb Ahead Brace yourself because this mining equipment racket is ramping up like you wouldn't believe. Analysts are telling us the market's supposed to roar from a $28.42 billion check in 2026 to a jaw-dropping $42.81 billion come 2033. That's a 6.0% CAGR—a figure that'll catch the eye of anyone not sound asleep at the wheel....

Continue Reading
Ascletis' Preclinical Successes: Future of Obesity Treatment

Updated Category News Views 84

Pharma Giants Eyeing a New Potential Well, it seems the world of pharma is buzzing with Ascletis’ latest developments in the obesity treatment arena. They’ve just showcased some intriguing preclinical data at ObesityWeek® 2026. The standout? A cocktail of advancements that might just put a dent in the obesity epidemic if further studies pan out. ASC30_48: A Daily...

Continue Reading
Guangdong's APEC Trade: Deep Ties, Big Stakes

Updated Category News Views 226

A New Chapter in Guangdong's Economic Story Swing by the bustling streets of Shenzhen, and you'll catch more than a whiff of change in the air. With China gearing up to host the APEC Economic Leaders' Meeting for the third time, Guangdong is under the magnifying glass. But it's not just the international attention landing on the province that’s worth the chatter —...

Continue Reading
Dar Global Expands Jeddah Portfolio with $267M Project

Updated Category News Views 77

Dar Global's Big Jeddah Move: A $267M Bet Alright, let's dive into what Dar Global's been up to in Saudi Arabia. They've just announced a whopping SAR 1 billion development project in Jeddah, bringing an international luxury brand to the city with an exclusive co-branded residential concept. Now that's something to chew on for any investor eyeing the Middle East's real...

Continue Reading
DemandTec Leads the Pack in Retail Pricing Arena

Updated Category News Views 12

DemandTec's Climb to Retail Pricing Stardom The news hitting the streets is that DemandTec's carved out a top spot in QKS Group's SPARK Matrix™ for Intelligent Retail Pricing & Promotion Optimization for 2026. In an industry filled with slick operators and gimmicks, it takes some real chops to stand out. They've clinched this position by rolling out a platform that ties...

Continue Reading
ELEGRP Makes Dyson Supersonic Global Voltage Ready

Updated Category News Views 36

Plugging Into the Future of Travel ELEGRP's latest move brings the Dyson Supersonic Travel hair dryer into the limelight, all decked out with global voltage compatibility. It's like the Swiss Army knife of hair dryers—one minute it’s working on 100V, next it’s flipping over to a juicy 240V, without breaking a sweat. The ALCI Difference: Safety Takes Center Stage...

Continue Reading
Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 87

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading

Top 5 Most Recently Viewed Articles

Steel Dynamics Insider Sell: Key Insights and Future Outlook

Updated Category News Views 91

Understanding Recent Insider Transactions at Steel Dynamics In a noteworthy development, James Stanley Anderson, the Senior Vice President of Steel Dynamics (NASDAQ: STLD), executed a substantial sell-off of shares, raising eyebrows among investors and industry analysts alike. This insider transaction, reported through an SEC filing, includes the sale of 10,000 shares,...

Continue Reading
Final Cash Distributions for iShares Premium Money Market ETF

Updated Category News Views 182

Final Cash Distributions Announced BlackRock Asset Management Canada Limited has recently revealed significant cash distributions for the iShares Premium Money Market ETF. This announcement, which is essential for investors looking to optimize their financial strategies, includes details on the cash distributions that will be made available for unitholders. Distribution...

Continue Reading
Sina Corporation Investors Encouraged to Join Class Action

Updated Category News Views 161

Sina Corporation Investors Encouraged to Join Class Action Attention investors of Sina Corporation (NASDAQ:SINA): If you've experienced significant financial losses related to the company's stock, you have a valuable opportunity to take action. A class action lawsuit has been initiated against Sina and its executives. Understanding the Class Action The lawsuit has been...

Continue Reading
Talisker’s Bralorne Gold Project Shows Thriving Ore Sorting Potential

Updated Category News Views 258

Talisker’s Innovative Approach to Ore Sorting Talisker Resources Ltd. is excited to share that promising outcomes have surfaced from its initial testing of ore sorting technologies at the Bralorne Gold Project. This flagship site, situated in British Columbia, is undergoing a revitalization aimed at enhancing gold recovery processes. The success of these technologies...

Continue Reading
Avalanche Experiences Significant Price Surge of 5.53% in One Day

Updated Category News Views 79

Avalanche Sees Impressive Market Performance Avalanche (AVAX) has demonstrated a remarkable surge in the cryptocurrency market, with its price climbing 5.53% in just 24 hours, now sitting at $29.11. This impressive rise is part of a larger trend, as the coin has seen a weekly increase of over 10%, up from $26.40. Notably, the coin has reached an all-time high of $144.96,...

Continue Reading